Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score‐matched study from the <span style="font-variant:small-caps;">FRANCOGYN</span> group

Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score‐matched study from the FRANCOGYN group. Wohrer, Henri; Koual, Meriem; Bentivegna, Enrica; Benoit, Louise; Metairie, Marie; Bolze, Pierre‐Adrien; Kerbage, Yohan; Raimond, Emilie; Akladios, Cherif; Carcopino, Xavier; Canlorbe, Geoffroy; Uzan, Jennifer; Lavoue, Vincent; Mimoun, Camille; Huchon, Cyrille; Koskas, Martin; Costaz, Hélène; Margueritte, François; Dabi, Yohann; Touboul, Cyril; Bendifallah, Sofiane; Ouldamer, Lobna; Delanoy, Nicolas; Nguyen‐Xuan, Huyen‐Thu; Bats, Anne‐Sophie; Azaïs, Henri. BJOG: An International Journal of Obstetrics & Gynaecology. 2023; 130: p.1511-1520. doi:10.1111/1471-0528.17524
Article